NCT07156084View on ClinicalTrials.gov

Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students

PHASE4RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

September 23, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

HPV Vaccine

Interventions

BIOLOGICAL

HPV nonavalent vaccine (Gardasil-9)

One dose HPV nonavalent vaccine

Trial Locations (1)

G1X4S9

RECRUITING

Centre de recherche du CHU de Québec-Université Laval, Québec

All Listed Sponsors

lead

Canadian Immunization Research Network

NETWORK

NCT07156084 - Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students | Biotech Hunter | Biotech Hunter